ALC
Price
$80.98
Change
-$0.17 (-0.21%)
Updated
Jan 30 closing price
Capitalization
40.1B
30 days until earnings call
Intraday BUY SELL Signals
CZMWY
Price
$33.22
Change
-$0.42 (-1.25%)
Updated
Jan 30 closing price
Capitalization
2.93B
11 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALC vs CZMWY

Header iconALC vs CZMWY Comparison
Open Charts ALC vs CZMWYBanner chart's image
Alcon
Price$80.98
Change-$0.17 (-0.21%)
Volume$1.22M
Capitalization40.1B
Carl Zeiss Meditec AG
Price$33.22
Change-$0.42 (-1.25%)
Volume$2.78K
Capitalization2.93B
ALC vs CZMWY Comparison Chart in %
ALC
Daily Signal:
Gain/Loss:
CZMWY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALC vs. CZMWY commentary
Feb 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a Buy and CZMWY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 01, 2026
Stock price -- (ALC: $80.98 vs. CZMWY: $33.22)
Brand notoriety: ALC and CZMWY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALC: 96% vs. CZMWY: 64%
Market capitalization -- ALC: $40.1B vs. CZMWY: $2.93B
ALC [@Pharmaceuticals: Other] is valued at $40.1B. CZMWY’s [@Pharmaceuticals: Other] market capitalization is $2.93B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $178.74B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.52B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALC’s FA Score shows that 0 FA rating(s) are green whileCZMWY’s FA Score has 1 green FA rating(s).

  • ALC’s FA Score: 0 green, 5 red.
  • CZMWY’s FA Score: 1 green, 4 red.
According to our system of comparison, CZMWY is a better buy in the long-term than ALC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALC’s TA Score shows that 4 TA indicator(s) are bullish while CZMWY’s TA Score has 4 bullish TA indicator(s).

  • ALC’s TA Score: 4 bullish, 3 bearish.
  • CZMWY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALC is a better buy in the short-term than CZMWY.

Price Growth

ALC (@Pharmaceuticals: Other) experienced а +0.86% price change this week, while CZMWY (@Pharmaceuticals: Other) price change was -0.72% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.17%. For the same industry, the average monthly price growth was +1.50%, and the average quarterly price growth was +26.40%.

Reported Earning Dates

ALC is expected to report earnings on Mar 03, 2026.

CZMWY is expected to report earnings on Feb 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.17% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALC($40.1B) has a higher market cap than CZMWY($2.93B). ALC has higher P/E ratio than CZMWY: ALC (38.56) vs CZMWY (17.23). ALC YTD gains are higher at: 2.753 vs. CZMWY (-29.063). ALC has higher annual earnings (EBITDA): 1.44B vs. CZMWY (347M). ALC has more cash in the bank: 1.5B vs. CZMWY (27.3M). CZMWY has less debt than ALC: CZMWY (132M) vs ALC (5.25B). ALC has higher revenues than CZMWY: ALC (10.2B) vs CZMWY (2.23B).
ALCCZMWYALC / CZMWY
Capitalization40.1B2.93B1,367%
EBITDA1.44B347M416%
Gain YTD2.753-29.063-9%
P/E Ratio38.5617.23224%
Revenue10.2B2.23B458%
Total Cash1.5B27.3M5,487%
Total Debt5.25B132M3,978%
FUNDAMENTALS RATINGS
ALC vs CZMWY: Fundamental Ratings
ALC
CZMWY
OUTLOOK RATING
1..100
6650
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
8579
PRICE GROWTH RATING
1..100
5792
P/E GROWTH RATING
1..100
5391
SEASONALITY SCORE
1..100
6565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CZMWY's Valuation (22) in the null industry is somewhat better than the same rating for ALC (76) in the Hospital Or Nursing Management industry. This means that CZMWY’s stock grew somewhat faster than ALC’s over the last 12 months.

ALC's Profit vs Risk Rating (69) in the Hospital Or Nursing Management industry is in the same range as CZMWY (100) in the null industry. This means that ALC’s stock grew similarly to CZMWY’s over the last 12 months.

CZMWY's SMR Rating (79) in the null industry is in the same range as ALC (85) in the Hospital Or Nursing Management industry. This means that CZMWY’s stock grew similarly to ALC’s over the last 12 months.

ALC's Price Growth Rating (57) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CZMWY (92) in the null industry. This means that ALC’s stock grew somewhat faster than CZMWY’s over the last 12 months.

ALC's P/E Growth Rating (53) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CZMWY (91) in the null industry. This means that ALC’s stock grew somewhat faster than CZMWY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALCCZMWY
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
49%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
64%
Bearish Trend 3 days ago
71%
MACD
ODDS (%)
Bullish Trend 3 days ago
60%
Bearish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
57%
Bearish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 6 days ago
57%
Bullish Trend 26 days ago
57%
Declines
ODDS (%)
Bearish Trend 10 days ago
57%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
58%
Bullish Trend 3 days ago
65%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ALC
Daily Signal:
Gain/Loss:
CZMWY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LMBS50.170.06
+0.12%
First Trust Low Duration Oppos ETF
DECT36.97-0.09
-0.24%
AllianzIM US Equity Buffer10 Dec ETF
ARLU30.67-0.13
-0.41%
AllianzIM U.S. Equity Buffer15 UncAprETF
GXC102.05-2.32
-2.22%
State Street® SPDR® S&P® China ETF
TSMG27.53-1.57
-5.39%
Leverage Shares 2X Long Tsm Daily ETF

ALC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALC
1D Price
Change %
ALC100%
-0.21%
SYK - ALC
54%
Loosely correlated
+4.31%
A - ALC
54%
Loosely correlated
+0.44%
DHR - ALC
53%
Loosely correlated
-0.33%
TMO - ALC
53%
Loosely correlated
-2.29%
COO - ALC
52%
Loosely correlated
+1.26%
More

CZMWY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CZMWY has been loosely correlated with SMMNY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CZMWY jumps, then SMMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CZMWY
1D Price
Change %
CZMWY100%
-1.25%
SMMNY - CZMWY
44%
Loosely correlated
-1.03%
SONVY - CZMWY
38%
Loosely correlated
-0.98%
SAUHY - CZMWY
37%
Loosely correlated
-0.08%
ALGN - CZMWY
37%
Loosely correlated
-0.66%
ALC - CZMWY
36%
Loosely correlated
-0.21%
More